Compare ITRG & PSNL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ITRG | PSNL |
|---|---|---|
| Founded | 1997 | 2011 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Precious Metals | Medical Specialities |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 482.5M | 746.8M |
| IPO Year | N/A | 2019 |
| Metric | ITRG | PSNL |
|---|---|---|
| Price | $3.79 | $7.90 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 7 |
| Target Price | $4.13 | ★ $10.71 |
| AVG Volume (30 Days) | ★ 1.7M | 1.4M |
| Earning Date | 11-12-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.08 | N/A |
| Revenue | ★ $219,125,000.00 | $69,103,000.00 |
| Revenue This Year | $965.93 | N/A |
| Revenue Next Year | $9.39 | $20.33 |
| P/E Ratio | $50.49 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.79 | $2.83 |
| 52 Week High | $4.69 | $11.40 |
| Indicator | ITRG | PSNL |
|---|---|---|
| Relative Strength Index (RSI) | 47.55 | 41.51 |
| Support Level | $3.98 | $7.88 |
| Resistance Level | $4.52 | $9.10 |
| Average True Range (ATR) | 0.25 | 0.47 |
| MACD | -0.08 | -0.09 |
| Stochastic Oscillator | 13.50 | 12.87 |
Integra Resources Corp is a precious metals exploration and development company in the Great Basin of the Western USA. Integra is currently focused on advancing its two flagship oxide heap leach projects: the past-producing DeLamar Project located in southwestern Idaho and the Nevada North Project, comprised of the Wildcat and Mountain View deposits, located in northwestern Nevada. The company also holds a portfolio of prospective early-stage exploration projects in Idaho, Nevada, and Arizona.
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.